Cargando…

Prostate Cancer Theranostics - An Overview

Metastatic prostate cancer is incurable, and novel methods to detect the disease earlier and to direct definitive treatment are needed. Molecularly specific tools to localize diagnostic and cytotoxic radionuclide payloads to cancer cells and the surrounding microenvironment are recognized as a criti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abou, Diane, Benabdallah, Nadia, Jiang, Wen, Peng, Lu, Zhang, Hanwen, Villmer, Alexandria, Longtine, Mark S., Thorek, Daniel L. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290246/ https://www.ncbi.nlm.nih.gov/pubmed/32582550 http://dx.doi.org/10.3389/fonc.2020.00884

Ejemplares similares

Cure of Disseminated Human Lymphoma with [(225)Ac]Ac-Ofatumumab in a Preclinical Model
por: Longtine, Mark S., et al.
Publicado: (2023)

Evaluation of Candidate Theranostics for (227)Th/(89)Zr Paired Radioimmunotherapy of Lymphoma
por: Abou, Diane S., et al.
Publicado: (2023)

[(18)F]-Labeled PARP-1 PET imaging of PSMA targeted alpha particle radiotherapy response
por: Zhang, Hanwen, et al.
Publicado: (2022)

Towards the stable chelation of radium for biomedical applications with an 18-membered macrocyclic ligand
por: Abou, Diane S., et al.
Publicado: (2021)

Clinical advancement of precision theranostics in prostate cancer
por: Tan, Yue, et al.
Publicado: (2023)

Engineering a modular (44)Ti/(44)Sc generator: eluate evaluation in preclinical models and estimation of human radiation dosimetry
por: Benabdallah, Nadia, et al.
Publicado: (2023)

Cure of Disseminated Human Lymphoma with [(177)Lu]Lu-Ofatumumab in a Preclinical Model
por: Shim, Kyuhwan, et al.
Publicado: (2023)

Improved (223)Ra Therapy with Combination Epithelial Sodium Channel Blockade
por: Abou, Diane S., et al.
Publicado: (2021)

Incorporating PSMA-Targeting Theranostics Into Personalized Prostate Cancer Treatment: a Multidisciplinary Perspective
por: Ng, Thomas S. C., et al.
Publicado: (2021)

Ovarian Cancer Targeted Theranostics
por: Nimmagadda, Sridhar, et al.
Publicado: (2020)

Blind Image Restoration Enhances Digital Autoradiographic Imaging of Radiopharmaceutical Tissue Distribution
por: Peng, Lu, et al.
Publicado: (2022)

Fibroblast activation protein-based theranostics in pancreatic cancer
por: Cheng, Chien-shan, et al.
Publicado: (2022)

Combined biology-guided radiotherapy and Lutetium PSMA theranostics treatment in metastatic castrate-resistant prostate cancer
por: Gaudreault, Mathieu, et al.
Publicado: (2023)

Nanozymes in Tumor Theranostics
por: Ma, Qiulian, et al.
Publicado: (2021)

Path to Clonal Theranostics in Luminal Breast Cancers
por: Hajjaji, Nawale, et al.
Publicado: (2022)

GRPR versus PSMA: expression profiles during prostate cancer progression demonstrate the added value of GRPR-targeting theranostic approaches
por: Verhoeven, Marjolein, et al.
Publicado: (2023)

Theranostic (64)Cu-DOTHA(2)-PSMA allows low toxicity radioligand therapy in mice prostate cancer model
por: Milot, Marie-Christine, et al.
Publicado: (2023)

Editorial: Radiomics-based theranostics in cancer precision medicine
por: Ji, Jiansong, et al.
Publicado: (2023)

Theranostic digital twins for personalized radiopharmaceutical therapies: Reimagining theranostics via computational nuclear oncology
por: Rahmim, Arman, et al.
Publicado: (2022)

Whole-Body and Microenvironmental Localization of Radium-223 in Naïve and Mouse Models of Prostate Cancer Metastasis
por: Abou, Diane S., et al.
Publicado: (2015)

Editorial: Tumor microenvironment targeted nanomedicine: a feasible strategy for cancer imaging and theranostics
por: Xu, Yiming, et al.
Publicado: (2023)

A Review of 177Lutetium-PSMA and 225Actinium-PSMA as Emerging Theranostic Agents in Prostate Cancer
por: Alam, Mohammad R, et al.
Publicado: (2022)

Biomimetic Nanoparticles Camouflaged in Cancer Cell Membranes and Their Applications in Cancer Theranostics
por: Jin, Jiefu, et al.
Publicado: (2020)

Preclinical efficacy of hK2 targeted [(177)Lu]hu11B6 for prostate cancer theranostics
por: Timmermand, Oskar Vilhelmsson, et al.
Publicado: (2019)

Theranostic Pretargeting Drug Delivery and Imaging Platforms in Cancer Precision Medicine
por: Hapuarachchige, Sudath, et al.
Publicado: (2020)

The Current Status and Future Potential of Theranostics to Diagnose and Treat Childhood Cancer
por: Poot, Alex J., et al.
Publicado: (2020)

MicroRNAs Role in Breast Cancer: Theranostic Application in Saudi Arabia
por: Alyami, Nouf M.
Publicado: (2021)

Diagnostic Performance of Theranostic Radionuclides Used in Transarterial Radioembolization for Liver Cancer
por: Li, Rou, et al.
Publicado: (2021)

Tunable Plasmonic Nanoprobes for Theranostics of Prostate Cancer
por: Lukianova-Hleb, Ekaterina Y., et al.
Publicado: (2011)

Co-Development of Diagnostic Vectors to Support Targeted Therapies and Theranostics: Essential Tools in Personalized Cancer Therapy
por: Nicolaides, Nicholas C., et al.
Publicado: (2014)

A Projection-Domain Low-Count Quantitative SPECT Method for α-Particle-Emitting Radiopharmaceutical Therapy
por: Li, Zekun, et al.
Publicado: (2023)

Current status of theranostics in prostate cancer
por: Virgolini, Irene, et al.
Publicado: (2017)

Advanced nanomaterial for prostate cancer theranostics
por: Hao, Bin, et al.
Publicado: (2022)

Dairy product consumption and development of cancer: an overview of reviews
por: Jeyaraman, Maya M, et al.
Publicado: (2019)

PSMA expression in the Hi‐Myc model; extended utility of a representative model of prostate adenocarcinoma for biological insight and as a drug discovery tool
por: Simons, Brian W., et al.
Publicado: (2019)

Mechanical Properties in the Glioma Microenvironment: Emerging Insights and Theranostic Opportunities
por: Bhargav, Adip G., et al.
Publicado: (2022)

Retraction of “Tunable Plasmonic Nanoprobes for Theranostics of Prostate Cancer”
por: Lukianova-Hleb, Ekaterina Y., et al.
Publicado: (2017)

PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic Outlook
por: Kirchner, Maximilian A., et al.
Publicado: (2021)

Prospects for Theranostics in Neurosurgical Imaging: Empowering Confocal Laser Endomicroscopy Diagnostics via Deep Learning
por: Izadyyazdanabadi, Mohammadhassan, et al.
Publicado: (2018)

Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patients
por: Stevens, Claire, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_95m8hnshcosrpnhbh9n2g9ai9s